Which has better valuation & earnings, ZEPP or SILC?

Silicom has lower revenue, but higher earnings than Zepp Health. Silicom is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zepp Health $258.90M 0.29 -$40.07M -$2.52 N/A Silicom $61.93M 3.72 -$11.48M -$1.93 N/A

Is ZEPP or SILC more profitable?

Zepp Health has a net margin of -14.70% compared to Silicom's net margin of -16.57%. Silicom's return on equity of -9.30% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% Silicom -16.57% -9.30% -7.24%

Does the media favor ZEPP or SILC?

In the previous week, Silicom had 2 more articles in the media than Zepp Health. MarketBeat recorded 3 mentions for Silicom and 1 mentions for Zepp Health. Silicom's average media sentiment score of 0.87 beat Zepp Health's score of 0.52 indicating that Silicom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Silicom 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, RDCM or ZEPP?

Radcom has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Radcom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Radcom $71.49M 3.17 $11.99M $0.75 18.05 Zepp Health $258.90M 0.29 -$40.07M -$2.52 N/A

Is RDCM or ZEPP more profitable?

Radcom has a net margin of 17.18% compared to Zepp Health's net margin of -14.70%. Radcom's return on equity of 11.68% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Radcom 17.18% 11.68% 9.16% Zepp Health -14.70% -15.64% -6.03%

Does the media refer more to RDCM or ZEPP?

In the previous week, Radcom had 2 more articles in the media than Zepp Health. MarketBeat recorded 3 mentions for Radcom and 1 mentions for Zepp Health. Radcom's average media sentiment score of 0.94 beat Zepp Health's score of 0.52 indicating that Radcom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Radcom 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ZEPP or LTRX more profitable?

Lantronix has a net margin of -5.52% compared to Zepp Health's net margin of -14.70%. Lantronix's return on equity of -6.79% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% Lantronix -5.52% -6.79% -4.17%

Does the media favor ZEPP or LTRX?

In the previous week, Lantronix had 5 more articles in the media than Zepp Health. MarketBeat recorded 6 mentions for Lantronix and 1 mentions for Zepp Health. Lantronix's average media sentiment score of 0.60 beat Zepp Health's score of 0.52 indicating that Lantronix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lantronix 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ZEPP or ALOT?

Zepp Health presently has a consensus target price of $56.28, suggesting a potential upside of 994.30%. Given Zepp Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Zepp Health is more favorable than AstroNova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zepp Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 AstroNova 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ZEPP or ALOT more profitable?

AstroNova has a net margin of -0.88% compared to Zepp Health's net margin of -14.70%. AstroNova's return on equity of 2.94% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% AstroNova -0.88% 2.94% 1.61%

Which has higher valuation & earnings, VTIX or ZEPP?

Virtuix has higher earnings, but lower revenue than Zepp Health. Virtuix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Virtuix $4.25M 20.59 -$13.87M -$0.48 N/A Zepp Health $258.90M 0.29 -$40.07M -$2.52 N/A

Is VTIX or ZEPP more profitable?

Virtuix has a net margin of 0.00% compared to Zepp Health's net margin of -14.70%. Virtuix's return on equity of 0.00% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Virtuix N/A N/A N/A Zepp Health -14.70% -15.64% -6.03%

Does the media prefer VTIX or ZEPP?

In the previous week, Virtuix had 3 more articles in the media than Zepp Health. MarketBeat recorded 4 mentions for Virtuix and 1 mentions for Zepp Health. Virtuix's average media sentiment score of 1.49 beat Zepp Health's score of 0.52 indicating that Virtuix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Virtuix 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Zepp Health (ZEPP) Competitors

$5.14 -0.23 (-4.23%)

Closing price 07/16/2026 03:58 PM Eastern

Extended Trading

$5.17 +0.03 (+0.52%)

As of 04:04 AM Eastern

Compare

ZEPP vs. SILC, RDCM, LTRX, ALOT, and VTIX

Should you buy Zepp Health stock or one of its competitors? MarketBeat compares Zepp Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zepp Health include Silicom (SILC), Radcom (RDCM), Lantronix (LTRX), AstroNova (ALOT), and Virtuix (VTIX). These companies are all part of the "computer hardware" industry.

How does Zepp Health compare to Silicom?

Zepp Health (NYSE:ZEPP) and Silicom (NASDAQ:SILC) are both small-cap computer hardware companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 52.9% of Silicom shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 25.4% of Silicom shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Zepp Health has a net margin of -14.70% compared to Silicom's net margin of -16.57%. Silicom's return on equity of -9.30% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
Silicom	-16.57%	-9.30%	-7.24%

Zepp Health has a beta of 1.83, indicating that its share price is 83% more volatile than the broader market. Comparatively, Silicom has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

In the previous week, Silicom had 2 more articles in the media than Zepp Health. MarketBeat recorded 3 mentions for Silicom and 1 mentions for Zepp Health. Silicom's average media sentiment score of 0.87 beat Zepp Health's score of 0.52 indicating that Silicom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Silicom	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Silicom has lower revenue, but higher earnings than Zepp Health. Silicom is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.29	-$40.07M	-$2.52	N/A
Silicom	$61.93M	3.72	-$11.48M	-$1.93	N/A

Zepp Health currently has a consensus price target of $56.28, indicating a potential upside of 994.30%. Silicom has a consensus price target of $60.00, indicating a potential upside of 49.78%. Given Zepp Health's higher possible upside, equities research analysts clearly believe Zepp Health is more favorable than Silicom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Silicom	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Zepp Health and Silicom tied by winning 7 of the 14 factors compared between the two stocks.

How does Zepp Health compare to Radcom?

Radcom (NASDAQ:RDCM) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

In the previous week, Radcom had 2 more articles in the media than Zepp Health. MarketBeat recorded 3 mentions for Radcom and 1 mentions for Zepp Health. Radcom's average media sentiment score of 0.94 beat Zepp Health's score of 0.52 indicating that Radcom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Radcom	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Radcom presently has a consensus price target of $18.00, suggesting a potential upside of 32.94%. Zepp Health has a consensus price target of $56.28, suggesting a potential upside of 994.30%. Given Zepp Health's higher possible upside, analysts plainly believe Zepp Health is more favorable than Radcom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Radcom	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Radcom has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Radcom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Radcom	$71.49M	3.17	$11.99M	$0.75	18.05
Zepp Health	$258.90M	0.29	-$40.07M	-$2.52	N/A

Radcom has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Zepp Health has a beta of 1.83, suggesting that its stock price is 83% more volatile than the broader market.

48.3% of Radcom shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 69.0% of Radcom shares are held by company insiders. Comparatively, 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Radcom has a net margin of 17.18% compared to Zepp Health's net margin of -14.70%. Radcom's return on equity of 11.68% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Radcom	17.18%	11.68%	9.16%
Zepp Health	-14.70%	-15.64%	-6.03%

Summary

Radcom beats Zepp Health on 11 of the 15 factors compared between the two stocks.

How does Zepp Health compare to Lantronix?

Zepp Health (NYSE:ZEPP) and Lantronix (NASDAQ:LTRX) are both small-cap computer hardware companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

Zepp Health has a beta of 1.83, indicating that its share price is 83% more volatile than the broader market. Comparatively, Lantronix has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

Lantronix has a net margin of -5.52% compared to Zepp Health's net margin of -14.70%. Lantronix's return on equity of -6.79% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
Lantronix	-5.52%	-6.79%	-4.17%

In the previous week, Lantronix had 5 more articles in the media than Zepp Health. MarketBeat recorded 6 mentions for Lantronix and 1 mentions for Zepp Health. Lantronix's average media sentiment score of 0.60 beat Zepp Health's score of 0.52 indicating that Lantronix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lantronix	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zepp Health currently has a consensus price target of $56.28, indicating a potential upside of 994.30%. Lantronix has a consensus price target of $10.40, indicating a potential upside of 92.24%. Given Zepp Health's higher probable upside, analysts plainly believe Zepp Health is more favorable than Lantronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lantronix	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

52.6% of Zepp Health shares are held by institutional investors. Comparatively, 39.4% of Lantronix shares are held by institutional investors. 36.0% of Zepp Health shares are held by insiders. Comparatively, 2.4% of Lantronix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Lantronix has lower revenue, but higher earnings than Zepp Health. Lantronix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.29	-$40.07M	-$2.52	N/A
Lantronix	$122.92M	1.94	-$11.37M	-$0.17	N/A

Summary

Lantronix beats Zepp Health on 10 of the 16 factors compared between the two stocks.

How does Zepp Health compare to AstroNova?

Zepp Health (NYSE:ZEPP) and AstroNova (NASDAQ:ALOT) are both small-cap computer hardware companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Zepp Health has a beta of 1.83, suggesting that its share price is 83% more volatile than the broader market. Comparatively, AstroNova has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

AstroNova has lower revenue, but higher earnings than Zepp Health. AstroNova is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.29	-$40.07M	-$2.52	N/A
AstroNova	$150.51M	1.47	-$2.38M	-$0.18	N/A

52.6% of Zepp Health shares are held by institutional investors. Comparatively, 43.0% of AstroNova shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 12.6% of AstroNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Zepp Health and Zepp Health both had 1 articles in the media. AstroNova's average media sentiment score of 1.89 beat Zepp Health's score of 0.52 indicating that AstroNova is being referred to more favorably in the news media.

Company	Overall Sentiment
Zepp Health	Positive
AstroNova	Very Positive

AstroNova has a net margin of -0.88% compared to Zepp Health's net margin of -14.70%. AstroNova's return on equity of 2.94% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
AstroNova	-0.88%	2.94%	1.61%

Zepp Health presently has a consensus target price of $56.28, suggesting a potential upside of 994.30%. Given Zepp Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Zepp Health is more favorable than AstroNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
AstroNova	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Zepp Health beats AstroNova on 8 of the 15 factors compared between the two stocks.

How does Zepp Health compare to Virtuix?

Virtuix (NASDAQ:VTIX) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

Virtuix presently has a consensus price target of $11.00, indicating a potential upside of 263.04%. Zepp Health has a consensus price target of $56.28, indicating a potential upside of 994.30%. Given Zepp Health's higher possible upside, analysts plainly believe Zepp Health is more favorable than Virtuix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virtuix	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Virtuix has higher earnings, but lower revenue than Zepp Health. Virtuix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virtuix	$4.25M	20.59	-$13.87M	-$0.48	N/A
Zepp Health	$258.90M	0.29	-$40.07M	-$2.52	N/A

52.6% of Zepp Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Virtuix had 3 more articles in the media than Zepp Health. MarketBeat recorded 4 mentions for Virtuix and 1 mentions for Zepp Health. Virtuix's average media sentiment score of 1.49 beat Zepp Health's score of 0.52 indicating that Virtuix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Virtuix	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Virtuix has a net margin of 0.00% compared to Zepp Health's net margin of -14.70%. Virtuix's return on equity of 0.00% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Virtuix	N/A	N/A	N/A
Zepp Health	-14.70%	-15.64%	-6.03%

Summary

Virtuix beats Zepp Health on 8 of the 13 factors compared between the two stocks.

Get Zepp Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZEPP vs. The Competition

Export

Metric	Zepp Health	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$78.83M	$1.84B	$6.96B	$23.43B
Dividend Yield	N/A	N/A	2.68%	4.19%
P/E Ratio	-2.04	76.81	27.20	31.08
Price / Sales	0.29	7.30	578.13	19.91
Price / Cash	N/A	28.11	49.25	33.10
Price / Book	0.35	5.50	10.74	4.78
Net Income	-$40.07M	-$54.76M	$3.59B	$1.07B
7 Day Performance	-4.30%	-1.46%	-1.92%	0.53%
1 Month Performance	-3.05%	4.46%	2.23%	2.19%
1 Year Performance	-63.19%	-2.41%	23.82%	17.07%

Zepp Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZEPP Zepp Health	2.4017 of 5 stars	$5.14 -4.2%	$56.28 +994.3%	-59.8%	$78.83M	$258.90M	N/A	1,230
SILC Silicom	2.4656 of 5 stars	$43.12 +1.1%	$60.00 +39.1%	+158.8%	$247.07M	$61.93M	N/A	320	News Coverage
RDCM Radcom	3.5699 of 5 stars	$14.21 -1.3%	$18.00 +26.7%	+3.0%	$237.74M	$71.49M	18.94	280	Short Interest Increase
LTRX Lantronix	3.1098 of 5 stars	$5.37 +1.1%	$10.00 +86.2%	+72.8%	$236.17M	$122.92M	N/A	350	Analyst Forecast Short Interest Increase
ALOT AstroNova	0.4838 of 5 stars	$28.56 +0.1%	N/A	+155.0%	$221.30M	$150.51M	N/A	340	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ZEPP) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zepp Health (ZEPP) Competitors